AorticLab Italy srl
Via Ribes 5
10015 Colleretto Giacosa (TO)

Contact person: Franco Osta
Role: CEO
E-mail: franco.osta@aorticlab.ch
Phone: +39 333 93 26 753
Website: http://www.aorticlab.ch/

Founding Year: 2017
Employees: 5
Employees in R&D: 5
Fields of business: Medical devices / Biotech Healthcare

Keywords:
RESTORING, AORTIC VALVE FUNCTIONS, VITAL ORGANS, TRANSCATHETER, DEVICE, ISCHEMIC, HAEMODYNAMICS

Description

The current AorticLab development program is based on the development of a system aimed to restore the aortic valve leaflets’ pliability in order to recover as much as possible the original haemodynamics of the native valve.

The system is composed by two devices:

First device: Transcatheter Debridement Device (TDD) Fragments the dystrophic calcification on valves leaflet affected by structural deterioration. TDD is integrated with a temporary valve that allows the treatment for some minutes.

Second device: Transcatheter Antiembolic Filter (TAF) The device protects the patient against embolic cerebral or peripheral ischemic attacks during the above-mentioned procedures conducted on the diseased aortic valve. The devices can be adopted in TAVI procedure increasing the efficacy and safety because the AorticLab devices are compatible with all TAVI delivery systems.

Decalcifying the native aortic valve will provide a regular implant site for TAVI prostheses. The entiembolic filter will protect from ischemic attacks.


Start typing and press Enter to search

La directory delle organizzazioni è in costruzione

Puoi consultarla dalla versione vecchia del sito bioPmed

Vai alla pagina

×
La directory dei ricercatori è in costruzione

Puoi consultarla dalla versione vecchia del sito bioPmed

Vai alla pagina

×
La directory delle università e centri di ricerca è in costruzione

Puoi consultarla dalla versione vecchia del sito bioPmed

Vai alla pagina

×
La nuova area riservata è in costruzione

Puoi accedere all’area riservata facendo login sul vecchio sito bioPmed

Vai al vecchio sito bioPmed

×